Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
FIVE PRIME THERAPEUTICS, INC. (FPRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2022 |
SC 13G/A
| Rock Springs Capital Management LP reports a 0% stake in Five Prime Therapeutics, Inc. |
| 05/17/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 04/26/2021 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 04/22/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/19/2021 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Gifted 2,385 shares
@ $0
Gifted 795 shares
@ $0
Gifted 1,440 shares
@ $0
Gifted 2,460 shares
@ $0
Gifted 14,174 shares
@ $0
Granted 66,000 shares
@ $0
Disposed/sold 169,468 shares
@ $38, valued at
$6.4M
Disposed/sold 795 shares
@ $38, valued at
$30.2k
Disposed/sold 4,747 options to buy
@ $8.49, valued at
$40.3k
Disposed/sold 9,142 options to buy
@ $5.54, valued at
$50.6k
Disposed/sold 12,063 options to buy
@ $7.26, valued at
$87.6k
|
|
| 04/19/2021 |
4
| Smith David V (Executive Vice President & CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Granted 66,000 shares
@ $0
Disposed/sold 138,947 shares
@ $38, valued at
$5.3M
Disposed/sold 185,000 options to buy
@ $12.47, valued at
$2.3M
Disposed/sold 90,000 options to buy
@ $5.25, valued at
$472.5k
|
|
| 04/19/2021 |
4
| Collins Helen Louise (EVP and Chief Medical Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Gifted 8,085 shares
@ $0
Granted 66,000 shares
@ $0
Disposed/sold 135,547 shares
@ $38, valued at
$5.2M
Disposed/sold 60,000 options to buy
@ $37.89, valued at
$2.3M
Disposed/sold 50,000 options to buy
@ $18.69, valued at
$934.5k
Disposed/sold 58,000 options to buy
@ $11.97, valued at
$694.3k
Disposed/sold 20,000 options to buy
@ $5.78, valued at
$115.6k
Disposed/sold 90,000 options to buy
@ $5.25, valued at
$472.5k
|
|
| 04/19/2021 |
4
| White David (See Remarks) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Disposed/sold 33,423 shares
@ $38, valued at
$1.3M
Disposed/sold 30,000 options to buy
@ $11.58, valued at
$347.4k
Disposed/sold 25,000 options to buy
@ $5.25, valued at
$131.3k
|
|
| 04/19/2021 |
4
| RINGO WILLIAM R (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Gifted 10,000 shares
@ $0
Disposed/sold 16,600 options to buy
@ $11.65, valued at
$193.4k
Disposed/sold 12,500 options to buy
@ $22.15, valued at
$276.9k
Disposed/sold 10,000 options to buy
@ $29.8, valued at
$298k
Disposed/sold 10,000 options to buy
@ $17.27, valued at
$172.7k
Disposed/sold 15,000 options to buy
@ $6.09, valued at
$91.4k
Disposed/sold 34,451 options to buy
@ $3.79, valued at
$130.6k
Disposed/sold 46,939 options to buy
@ $3.99, valued at
$187.3k
Disposed/sold 50,367 options to buy
@ $3.23, valued at
$162.7k
Disposed/sold 49,552 options to buy
@ $3.94, valued at
$195.2k
Disposed/sold 40,868 options to buy
@ $5.31, valued at
$217k
|
|
| 04/19/2021 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Disposed/sold 5,000 shares
@ $38, valued at
$190k
Disposed/sold 12,500 options to buy
@ $22.15, valued at
$276.9k
Disposed/sold 10,000 options to buy
@ $29.8, valued at
$298k
Disposed/sold 10,000 options to buy
@ $17.27, valued at
$172.7k
Disposed/sold 15,000 options to buy
@ $6.09, valued at
$91.4k
Disposed/sold 20,000 options to buy
@ $4.14, valued at
$82.8k
|
|
| 04/19/2021 |
4
| Dhingra Kapil (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Disposed/sold 25,000 options to buy
@ $37.99, valued at
$949.8k
Disposed/sold 10,000 options to buy
@ $29.8, valued at
$298k
Disposed/sold 10,000 options to buy
@ $17.27, valued at
$172.7k
Disposed/sold 15,000 options to buy
@ $6.09, valued at
$91.4k
Disposed/sold 20,000 options to buy
@ $4.14, valued at
$82.8k
|
|
| 04/19/2021 |
4
| Jensen Peder (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Disposed/sold 12,500 options to buy
@ $12.7, valued at
$158.8k
Disposed/sold 12,500 options to buy
@ $22.15, valued at
$276.9k
Disposed/sold 10,000 options to buy
@ $29.8, valued at
$298k
Disposed/sold 10,000 options to buy
@ $17.27, valued at
$172.7k
Disposed/sold 15,000 options to buy
@ $6.09, valued at
$91.4k
Disposed/sold 20,000 options to buy
@ $4.14, valued at
$82.8k
|
|
| 04/19/2021 |
4
| Nicholson Garry A (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Disposed/sold 15,000 options to buy
@ $29.8, valued at
$447k
Disposed/sold 10,000 options to buy
@ $17.27, valued at
$172.7k
Disposed/sold 15,000 options to buy
@ $6.09, valued at
$91.4k
Disposed/sold 20,000 options to buy
@ $4.14, valued at
$82.8k
|
|
| 04/19/2021 |
4
| SCHAFER CAROL (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Disposed/sold 25,000 options to buy
@ $9.17, valued at
$229.3k
Disposed/sold 1,250 options to buy
@ $6.09, valued at
$7.6k
Disposed/sold 20,000 options to buy
@ $4.14, valued at
$82.8k
|
|
| 04/19/2021 |
4
| Lyons-Williams Lori (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Disposed/sold 25,000 options to buy
@ $6.3, valued at
$157.5k
Disposed/sold 20,000 options to buy
@ $4.14, valued at
$82.8k
|
|
| 04/19/2021 |
4
| Civik Thomas (President and CEO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Disposed/sold 68,971 shares
@ $38, valued at
$2.6M
Disposed/sold 480,000 options to buy
@ $2.72, valued at
$1.3M
|
|
| 04/16/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/16/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/16/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/16/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/16/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/16/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/16/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/16/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/16/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/16/2021 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 04/16/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 04/16/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 04/16/2021 |
8-K
| Resignation/termination of a director |
| 04/15/2021 |
8-K
| Other Events Interactive Data |
| 04/13/2021 |
4
| Civik Thomas (President and CEO) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 11,088 shares
@ $37.94, valued at
$420.7k
|
|
| 04/08/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 04/08/2021 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 04/06/2021 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
|
|
|